Twins reliever Cole Sands set for season-ending surgery
The Twins reliever will have arthroscopic surgery and a platelet-rich plasma injection after nearly three months of rehab setbacks, the team said.
- On Thursday, the Twins announced reliever Cole Sands requires season-ending elbow surgery following nearly three months of rehab assignments and multiple setbacks.
- Team director of medical high performance Dr. Chris Camp will perform the procedure on Tuesday, removing loose bodies and bone spurs from Sands' right elbow.
- Sands described the rehab process as inconsistent, noting "it was very tough to pitch through," with often one good day followed by two or three bad days.
- Combining the scope with a PRP injection aims to streamline recovery; Sands expects to enter the offseason "pretty much normal" and "ready to go."
- Sands hopes the surgery enables him to "come into next year ready to go," while the Twins also addressed David Festa, who underwent successful arthroscopic surgery Wednesday.
17 Articles
17 Articles
Pioneer Press
Twins reliever Cole Sands set for season-ending surgery
He recorded one out, gave up five runs and, most importantly, didn’t feel right in his Sunday return.
Twins' Cole Sands Set for Elbow Surgery, Out for Season
Twin right-hander Cole Sands is set for elbow surgery to remove loose bodies and bone spurs, sidelining him for the remainder of the season. He recently returned from a forearm strain but struggled upon re-entry, allowing five earned runs in just one out. Sands' performance had noticeably declined, with his pitch velocity dropping significantly this year. Despite this setback, the Twins plan to continue their search for bullpen reinforcements. T…
Sands' season over; Rojas' usage; Lackey's debut
MINNEAPOLIS -- A frustrating year for Cole Sands is officially coming to an end. Sands, who has battled right elbow trouble since the end of April, will undergo arthroscopic surgery on the joint on Tuesday and will not pitch again in 2026. Sands will also receive a PRP injection. The
Coverage Details
Bias Distribution
- 67% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
